Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 197 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 94 |
|
Comprehensive Epilepsy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 318 |
|
Hemiplegic Migraine Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 2 | 9 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene US, LLC - The Rare Disease Company United States | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene US, LLC - The Rare Disease Company United States | 442 | 443 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 78 | 76 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 777 | 770 |
|
ATP1A3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
ATP1A3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 342 | 156 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.